Vertebrobasilar Artery Syndrome Treatment Market Share

APAC Market Statistics

The market share of vertebrobasilar artery syndrome treatment in Asia Pacific, amongst the market in all the other regions, is projected to be the largest with a share of about 35% by the end of 2036. The market in the Asia Pacific region is forecasted to witness substantial growth during the forecast period on the back of emergent healthcare infrastructure and improvement in medical facilities in developing nations, such as India, China, Bangladesh, Singapore, and Indonesia, among others. In addition to this, the high geriatric population in the APAC region is estimated to boost the market growth. According to the data by the World Bank, 6.574% of the total population of India aged above 65 years, in 2020, while the same value for China is 11.96% of the total population. Moreover, favorable market policies in these countries, attracting international investment, along with the growing disposable income are estimated to boost the market growth.

North American Market Forecast

The North American market is estimated to be the second largest, registering a share of about 24% by the end of 2036, on account of high healthcare expenditure, presence of major pharmaceutical companies, and increasing expenditure in R&D activities. According to the statistics by the World Bank, in 2018, North America spent USD 10,050.516 for the healthcare of every individual. The total healthcare expenditure accounted for 16.415% of the total GDP of North America. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies are also anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare industry and rising commercialization of medical products are also anticipated to boost market growth during the forecast period.

Europe Market Forecast

Further, the market in the European region, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2036. The growth of the market in this region can be attributed to the presence of key players in this region. Hence, owing to these key players Europe plays an important role in vertebrobasilar artery syndrome treatment as compared to other regions. These key players are further boosting their production in order to satisfy the demands of various organizations.